HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eduardo Reyes Selected Research
Eduardo Reyes Research Topics
Disease
33
Prostatic Neoplasms (Prostate Cancer)
08/2022 - 06/2010
16
Neoplasms (Cancer)
01/2020 - 01/2003
9
Neoplasm Metastasis (Metastasis)
07/2022 - 01/2018
9
Residual Neoplasm
07/2021 - 12/2017
4
Neoplasm Micrometastasis
01/2020 - 06/2010
4
Infections
11/2018 - 10/2002
3
Disease Progression
01/2018 - 01/2012
3
Necrosis
07/2010 - 04/2004
3
Fibrosis (Cirrhosis)
07/2010 - 04/2004
2
Inflammation (Inflammations)
11/2022 - 08/2005
2
Margins of Excision
01/2016 - 01/2015
2
Dengue (Dengue Fever)
09/2015 - 03/2014
2
Sepsis (Septicemia)
03/2013 - 06/2012
1
Hypothyroidism
10/2023
1
Extranodal Extension
01/2015
1
Skin Neoplasms (Skin Cancer)
04/2013
1
Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
03/2013
1
Prostatitis
01/2013
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2012
1
Thrombosis (Thrombus)
03/2012
1
Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
01/2012
1
Vasculitis (Vasculitides)
01/2012
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2012
1
Septic Shock (Toxic Shock Syndrome)
03/2011
1
Liver Cirrhosis (Hepatic Cirrhosis)
07/2010
1
Portal Hypertension
07/2010
1
Brucellosis (Malta Fever)
07/2010
1
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
07/2010
1
Chronic Obstructive Pulmonary Disease (COPD)
03/2006
1
Vitiligo
03/2006
1
Bacterial Infections (Bacterial Infection)
08/2005
1
Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
04/2004
1
Chemotherapy-Induced Febrile Neutropenia
01/2003
1
Neutropenia
01/2003
1
Fever (Fevers)
01/2003
1
Chronic Hepatitis C
10/2002
Drug/Important Bio-Agent (IBA)
20
cytidylyl-(3'-5')-cytidine (CpC)
IBA
07/2021 - 06/2010
7
Cytokines
IBA
11/2022 - 08/2005
6
Prostate-Specific Antigen (Semenogelase)
IBA
01/2020 - 04/2013
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2011 - 04/2004
4
Interleukin-6 (Interleukin 6)
IBA
11/2022 - 06/2006
3
Biomarkers (Surrogate Marker)
IBA
11/2019 - 03/2013
3
Immunologic Factors (Immunomodulators)
IBA
07/2010 - 03/2006
3
Immunoferon (AM3)
IBA
07/2010 - 03/2006
2
Ligands
IBA
09/2015 - 03/2014
2
Cytokine Receptors (Cytokine Receptor)
IBA
09/2015 - 03/2014
2
Enzymes
IBA
01/2013 - 07/2010
2
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
01/2012 - 09/2010
2
Interferon-gamma (Interferon, gamma)
IBA
07/2010 - 08/2005
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
10/2023
1
Buffers
IBA
11/2022
1
Dihydrotachysterol (AT 10)
IBA
01/2020
1
Immunoglobulins (Immunoglobulin)
IBA
11/2018
1
Indicators and Reagents (Reagents)
IBA
06/2017
1
Capsules (Microcapsules)
IBA
01/2016
1
Androgens
IBA
01/2015
1
TNF-Related Apoptosis-Inducing Ligand
IBA
03/2014
1
Interleukin-1 Receptor-Like 1 Protein
IBA
03/2014
1
Interleukin-12 (IL 12)
IBA
03/2014
1
Interleukin-17 (Interleukin 17)
IBA
03/2014
1
Interleukin-1 (Interleukin 1)
IBA
03/2014
1
Selectins
IBA
03/2013
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
03/2013
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
03/2013
1
E-Selectin
IBA
03/2013
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
06/2012
1
Heparin (Liquaemin)
FDA Link
Generic
03/2012
1
Bevacizumab (Avastin)
FDA Link
03/2012
1
Lupus Coagulation Inhibitor (Lupus Anticoagulant)
IBA
01/2012
1
Diphosphonates (Bisphosphonates)
IBA
01/2012
1
Anticoagulants
IBA
01/2012
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
03/2011
1
Interleukins
IBA
03/2011
1
Proteins (Proteins, Gene)
FDA Link
09/2010
1
Immunosorbents
IBA
07/2010
1
Messenger RNA (mRNA)
IBA
07/2010
1
Interleukin-2 (IL2)
IBA
07/2010
1
Interleukin-4 (Interleukin 4)
IBA
07/2010
1
Hydroxyproline (4 Hydroxyproline)
IBA
07/2010
1
Interleukin-10 (Interleukin 10)
IBA
07/2010
1
Interleukin-12 Subunit p40
IBA
07/2010
1
phorbol
IBA
07/2010
1
Myristic Acid (Tetradecanoic Acid)
IBA
07/2010
1
alpha 1 Chain Collagen Type I
IBA
07/2010
1
Interleukin-1beta (Interleukin 1 beta)
IBA
07/2010
1
Type I Tumor Necrosis Factor Receptors
IBA
06/2006
1
Norfloxacin
FDA Link
04/2004
1
Carrier Proteins (Binding Protein)
IBA
04/2004
1
Interferon-alpha (Interferon Alfa)
IBA
10/2002
1
Interferons
IBA
10/2002
Therapy/Procedure
23
Prostatectomy (Retropubic Prostatectomy)
08/2022 - 01/2013
6
Therapeutics
08/2022 - 01/2003
2
Radiotherapy
01/2020 - 01/2018
1
Time-to-Treatment
01/2020
1
Nephrectomy
01/2012
1
Aftercare (After-Treatment)
07/2010
1
PUVA Therapy
03/2006
1
Drug Therapy (Chemotherapy)
01/2003